93 related articles for article (PubMed ID: 21640094)
1. Performance evaluation of Elecsys analysis system for anti-cyclic citrullinated peptide detection in comparison with commercially available ELISA assays in rheumatoid arthritis diagnosis.
Cai B; Wang L; Liu J; Feng W
Clin Biochem; 2011 Aug; 44(12):989-93. PubMed ID: 21640094
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis].
Yang CL; Zhou YR; Zhou F; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1277-9. PubMed ID: 17715048
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of analytical and diagnostic performances of the anti-cyclic citrullinated peptides (anti-CCP) automated assay on Elecsys analyzer].
Chenevier-Gobeaux C; Simonneau C; Ekindjian OG; Weill B; Goulvestre C
Ann Biol Clin (Paris); 2009; 67(4):405-10. PubMed ID: 19654079
[TBL] [Abstract][Full Text] [Related]
5. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
6. Anti-cyclic citrullinated peptide antibodies: a comparison of different assays for the diagnosis of rheumatoid arthritis.
Debaugnies F; Servais G; Badot V; Noubouossie D; Willems D; Corazza F
Scand J Rheumatol; 2013; 42(2):108-14. PubMed ID: 23126558
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis.
Dejaco C; Klotz W; Larcher H; Duftner C; Schirmer M; Herold M
Arthritis Res Ther; 2006; 8(4):R119. PubMed ID: 16859519
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis.
Fernández-Suárez A; Reneses S; Wichmann I; Criado R; Núñez A
Clin Chem Lab Med; 2005; 43(11):1234-9. PubMed ID: 16232091
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays.
Vander Cruyssen B; Cantaert T; Nogueira L; Clavel C; De Rycke L; Dendoven A; Sebag M; Deforce D; Vincent C; Elewaut D; Serre G; De Keyser F
Arthritis Res Ther; 2006; 8(4):R122. PubMed ID: 16859515
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
13. Comparison of chemiluminescence enzyme immunoassay (CLEIA) with ELISA for the determination of anti-cyclic citrullinated peptide antibodies.
Tanaka R; Takemura M; Sato M; Yamada Y; Nakagawa T; Horibe T; Hoshi M; Otaki H; Ito H; Seishima M; Shimizu K
Clin Chim Acta; 2010 Jan; 411(1-2):22-5. PubMed ID: 19818336
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
15. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis.
Mutlu N; Bicakcigil M; Tasan DA; Kaya A; Yavuz S; Ozden AI
J Rheumatol; 2009 Mar; 36(3):491-500. PubMed ID: 19228660
[TBL] [Abstract][Full Text] [Related]
16. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
17. Performance characteristic of anti-cyclic citrullinated peptide (CCP) assay on Korean rheumatoid arthritis (RA) patients and healthy controls.
Pyun JC; Lee EH; Han H; Kim HY; Kim HO; Kang MJ
J Pharm Biomed Anal; 2014 Apr; 92():69-73. PubMed ID: 24503194
[TBL] [Abstract][Full Text] [Related]
18. Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis.
Lutteri L; Malaise M; Chapelle JP
Clin Chim Acta; 2007; 386(1-2):76-81. PubMed ID: 17826752
[TBL] [Abstract][Full Text] [Related]
19. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
20. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]